Publication at Faculty of Medicine in Hradec Králové |
2018
Abstract
Multiple sclerosis is a chronic inflammatory autoimmune disease which affect central nervous system. Treatment initiation ofearly multiple sclerosis may postpone thie development of disease progression and disablement.
Goal of MS treatment is statewithout cninical and sublinical markers of diseasety aktivity, state known as NEDA (No Evidence of Disease Activity). This work isconcerned with treatment of MS, monitoring and predictors of treatment.